Fortis Healthcare Limited has announced significant changes to its Board of Directors, effective September 09, 2025. The company has appointed Dr. Keith Hsiu Chin Lim as an Additional Director while bidding farewell to Tomo Nagahiro.

New Appointment

Dr. Keith Hsiu Chin Lim has been appointed as an Additional Director (Non-Executive & Non-Independent) of Fortis Healthcare. The appointment, based on the recommendation of the Nomination and Remuneration Committee, took effect from the close of business hours on September 09, 2025.

Director Resignation

Simultaneously, Tomo Nagahiro has stepped down from his position as Non-Executive & Non-Independent Director due to other commitments and responsibilities. His resignation is also effective from the close of business hours on September 09, 2025.

About Dr. Keith Hsiu Chin Lim

Dr. Lim brings a wealth of experience to Fortis Healthcare:

• Currently serves as Group Chief Medical Officer at IHH Healthcare
• Over 20 years of experience as a radiation oncologist
• Previously held positions at National University Health System (NUHS) and Singapore's Ministry of Health
• Recipient of Singapore's National Medical Excellence Award
• Holds a Bachelor of Medicine and Bachelor of Surgery (MBBS) from the National University of Singapore
• Fellow of the Royal Australian and New Zealand College of Radiologists

In his role at IHH Healthcare, Dr. Lim oversees clinical quality, patient safety, and value-based care across the group. His expertise includes setting policies and driving quality improvements to ensure world-class and cost-effective patient care.

Board Relationships

While Dr. Lim is not related to any of the company's directors, it's worth noting that he, along with Dr. Prem Kumar Nair, Mr. Dilip Kadambi, Mr. Ashok Pandit, and Mr. Lim Tsin Lin, serves as a nominee director of Northern TK Venture Pte. Ltd.

The board changes reflect Fortis Healthcare's ongoing commitment to maintaining strong leadership and expertise in the healthcare sector. As the company continues to evolve, these strategic appointments aim to further strengthen its position in the industry.

Fortis Healthcare , a leading Indian healthcare provider, has made a significant move to expand its presence in the National Capital Region (NCR). The company has entered into a strategic agreement for hospital land and equipment lease in Greater Noida, marking a potential boost to its operational capacity in the region.

Key Details of the Agreement

The agreement involves three parties:

1. Fortis Healthcare
2. Uttar Pradesh State Industrial Development Authority (UPSIDA)
3. R.R. Lifesciences Pvt Ltd

While the specific terms of the lease agreement have not been disclosed, this development signals Fortis Healthcare's commitment to expanding its healthcare services in the rapidly growing Greater Noida area.

Strategic Implications

This move by Fortis Healthcare could have several strategic implications:

• Expanded Footprint: The lease agreement allows Fortis to establish a presence in Greater Noida, potentially tapping into a new patient base.
• Asset-Light Model: By leasing land and equipment rather than purchasing, Fortis may be adopting an asset-light approach to expansion, which could be more cost-effective in the short term.
• Collaborative Approach: The involvement of UPSIDA and R.R. Lifesciences suggests a collaborative effort, possibly leveraging the strengths of each party involved.

Market Impact

The news of this lease agreement could be viewed positively by investors and stakeholders. It demonstrates Fortis Healthcare's proactive approach to growth and its strategy to enhance its presence in key urban areas.

As Greater Noida continues to develop as a major residential and commercial hub in the NCR, Fortis Healthcare's expansion into this area may position the company to meet the increasing healthcare demands of the growing population.

While the financial details of the agreement have not been revealed, the market will likely keep a close watch on how this development impacts Fortis Healthcare's operational capacity and future financial performance.

Fortis Healthcare continues to be a significant player in the Indian healthcare sector, and this latest move underscores its commitment to strategic expansion and service enhancement in key markets.